India’s Biopharma Ambition Is Changing What Manufacturers Need From Their Suppliers
India’s biopharma manufacturing capabilities have long been recognised globally, particularly in generics and vaccines. But the opportunity ahead is broader. As Indian companies move into complex biologics, biosimilars, advanced therapies and global contract manufacturing, the requirements from their manufacturing infrastructure are becoming more sophisticated too. This evolution is changing the role of biopharma equipment. Equipment […]